ES2187051T3 - Benzamidas gastrocineticas biciclicas de derivados de 4-(aminometil)-piperidina sustituidos en posicion 3 o 4. - Google Patents

Benzamidas gastrocineticas biciclicas de derivados de 4-(aminometil)-piperidina sustituidos en posicion 3 o 4.

Info

Publication number
ES2187051T3
ES2187051T3 ES98940158T ES98940158T ES2187051T3 ES 2187051 T3 ES2187051 T3 ES 2187051T3 ES 98940158 T ES98940158 T ES 98940158T ES 98940158 T ES98940158 T ES 98940158T ES 2187051 T3 ES2187051 T3 ES 2187051T3
Authority
ES
Spain
Prior art keywords
sup
sub
hydrogen
alkyl
alk
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98940158T
Other languages
English (en)
Spanish (es)
Inventor
Jean-Paul Rene Marie A Bosmans
Michel Anna Jozef De Cleyn
Michel Surkyn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Application granted granted Critical
Publication of ES2187051T3 publication Critical patent/ES2187051T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • C07D211/46Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/42Oxygen atoms attached in position 3 or 5
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10Laxatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/06Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • C07D211/48Oxygen atoms attached in position 4 having an acyclic carbon atom attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/12Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/14Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/14Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/16Radicals substituted by halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
ES98940158T 1997-07-11 1998-07-07 Benzamidas gastrocineticas biciclicas de derivados de 4-(aminometil)-piperidina sustituidos en posicion 3 o 4. Expired - Lifetime ES2187051T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97202180 1997-07-11
EP98200624 1998-02-27

Publications (1)

Publication Number Publication Date
ES2187051T3 true ES2187051T3 (es) 2003-05-16

Family

ID=26146699

Family Applications (2)

Application Number Title Priority Date Filing Date
ES98940158T Expired - Lifetime ES2187051T3 (es) 1997-07-11 1998-07-07 Benzamidas gastrocineticas biciclicas de derivados de 4-(aminometil)-piperidina sustituidos en posicion 3 o 4.
ES98939620T Expired - Lifetime ES2212330T3 (es) 1997-07-11 1998-07-07 Benzamidas gastrocineticas biciclicas de derivados de 4-(aminometil)-piperididina sustituidos en posicion 3 o 4.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES98939620T Expired - Lifetime ES2212330T3 (es) 1997-07-11 1998-07-07 Benzamidas gastrocineticas biciclicas de derivados de 4-(aminometil)-piperididina sustituidos en posicion 3 o 4.

Country Status (33)

Country Link
US (10) US6452013B1 (cs)
EP (3) EP1206938A1 (cs)
JP (2) JP2002508000A (cs)
KR (2) KR100500372B1 (cs)
CN (2) CN1117568C (cs)
AR (2) AR016324A1 (cs)
AT (2) ATE226820T1 (cs)
AU (2) AU747199B2 (cs)
BG (2) BG64230B1 (cs)
BR (2) BRPI9811688B8 (cs)
CA (2) CA2295088C (cs)
CZ (2) CZ297298B6 (cs)
DE (2) DE69820065T2 (cs)
DK (2) DK1000028T3 (cs)
EA (1) EA002619B1 (cs)
EE (1) EE04178B1 (cs)
ES (2) ES2187051T3 (cs)
HR (2) HRP20000005B1 (cs)
HU (2) HU227424B1 (cs)
ID (2) ID24481A (cs)
IL (2) IL133917A (cs)
MY (2) MY117803A (cs)
NO (2) NO317467B1 (cs)
NZ (2) NZ502208A (cs)
PL (2) PL190611B1 (cs)
PT (2) PT991410E (cs)
RU (1) RU2213089C2 (cs)
SI (2) SI1000028T1 (cs)
SK (2) SK284942B6 (cs)
TR (2) TR200000022T2 (cs)
TW (2) TW402591B (cs)
UA (1) UA67745C2 (cs)
WO (2) WO1999002156A1 (cs)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW402591B (en) 1997-07-11 2000-08-21 Janssen Pharmaceutica Nv Monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
TW570920B (en) * 1998-12-22 2004-01-11 Janssen Pharmaceutica Nv 4-(aminomethyl)-piperidine benzamides for treating gastrointestinal disorders
US20040253179A1 (en) * 2003-02-26 2004-12-16 Acm Medical Technologies, Inc. Measuring gastrointestinal parameters
US20080219928A1 (en) * 2003-02-26 2008-09-11 Becker Jane A Measuring Gastrointestinal Parameters
EP1615883A1 (en) * 2003-04-14 2006-01-18 Warner-Lambert Company Process for preparing 5-(4-fluorophenyl)-1-[2-((2r,4r)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1h-pyrrole-3-carboxylic acid phenylamide
JO2478B1 (en) * 2003-06-19 2009-01-20 جانسين فارماسوتيكا ان. في. (Aminomethyl) -biperidine benzamides as 5 HT4 antagonists
ES2293262T3 (es) * 2003-06-19 2008-03-16 Janssen Pharmaceutica N.V. 4-(aminometil)-piperidin benzamidas 5ht4-antagonistas.
WO2005000837A1 (en) * 2003-06-19 2005-01-06 Janssen Pharmaceutica N.V. Aminosulfonyl substituted 4-(aminomethyl)-piperidine benzamides as 5ht4-antagonists
ATE449093T1 (de) * 2003-06-19 2009-12-15 Janssen Pharmaceutica Nv Heterocyclisch substituierte 4-(aminomethyl)- piperidinbenzamide als 5ht4-antagonisten
DE602005005167T2 (de) * 2004-01-29 2009-04-30 Pfizer Inc. 1-isopropyl-2-oxo-1,2-dihydropyridin-3-carbonsäureamidderivate mit agonistischer wirkung am 5-ht4-rezeptor
TW200533348A (en) * 2004-02-18 2005-10-16 Theravance Inc Indazole-carboxamide compounds as 5-ht4 receptor agonists
WO2005092882A1 (en) * 2004-03-01 2005-10-06 Pfizer Japan, Inc. 4-amino-5-halogeno-benzamide derivatives as 5-ht4 receptor agonists for the treatment of gastrointestinal, cns, neurological and cardiovascular disorders
US7728006B2 (en) * 2004-04-07 2010-06-01 Theravance, Inc. Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
TWI351282B (en) * 2004-04-07 2011-11-01 Theravance Inc Quinolinone-carboxamide compounds as 5-ht4 recepto
US8309575B2 (en) 2004-04-07 2012-11-13 Theravance, Inc. Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
US9641902B2 (en) 2007-06-26 2017-05-02 Broadband Itv, Inc. Dynamic adjustment of electronic program guide displays based on viewer preferences for minimizing navigation in VOD program selection
ATE441646T1 (de) * 2004-11-05 2009-09-15 Theravance Inc 5-ht4-rezeptoragonistenverbindungen
EP1807423B1 (en) * 2004-11-05 2009-05-20 Theravance, Inc. Quinolinone-carboxamide compounds
US20070020330A1 (en) 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
JP5607291B2 (ja) 2004-11-24 2014-10-15 メダ ファーマシューティカルズ インコーポレイテッド アゼラスチンを含む組成物およびその使用方法
ATE469897T1 (de) * 2004-12-22 2010-06-15 Theravance Inc Indazolcarbonsäureamidverbindungen
NZ560828A (en) * 2005-03-02 2011-01-28 Theravance Inc Quinolinone compounds as 5-HT4 receptor agonists
TWI377206B (en) * 2005-04-06 2012-11-21 Theravance Inc Crystalline form of a quinolinone-carboxamide compound
GB0603550D0 (en) * 2006-02-22 2006-04-05 Glaxo Group Ltd Novel compounds
US8642772B2 (en) 2008-10-14 2014-02-04 Sk Biopharmaceuticals Co., Ltd. Piperidine compounds, pharmaceutical composition comprising the same and its use
US20110313319A1 (en) * 2008-11-07 2011-12-22 SAND COUNTY BIOTECHNOLOGY, Inc. Measuring method for the concentration of intragastric contents
US8232315B2 (en) 2009-06-26 2012-07-31 Sk Biopharmaceuticals Co., Ltd. Methods for treating drug addiction and improving addiction-related behavior
MX350745B (es) 2009-11-06 2017-09-14 Sk Biopharmaceuticals Co Ltd * El uso de un compuesto de carbamoilo para el tratamiento del sindrome de fibromialgia.
US8895609B2 (en) 2009-11-06 2014-11-25 Sk Biopharmaceuticals Co., Ltd. Methods for treating attention-deficit/hyperactivity disorder
KR101180174B1 (ko) 2010-04-23 2012-09-05 동아제약주식회사 신규한 벤즈아미드 유도체
US8623913B2 (en) 2010-06-30 2014-01-07 Sk Biopharmaceuticals Co., Ltd. Methods for treating restless legs syndrome
US9610274B2 (en) 2010-06-30 2017-04-04 Sk Biopharmaceuticals Co., Ltd. Methods for treating bipolar disorder
JP6182989B2 (ja) 2012-06-28 2017-08-23 セントラル硝子株式会社 1,3,3,3−テトラフルオロプロペンの製造方法
WO2014083003A1 (en) 2012-11-27 2014-06-05 Shire International Gmbh Pro-cognitive compound
ES2897946T3 (es) * 2013-07-25 2022-03-03 Dong A St Co Ltd Método para preparar un derivado de benzamida, intermedio novedoso utilizado en la preparación de la benzamida y método para preparar un intermedio novedoso
BR112022022184A2 (pt) * 2020-05-04 2023-01-17 Takeda Pharmaceuticals Co Derivados de n-(piperidin-4-il)benzamida agindo luminalmente
EP4393470A1 (en) 2022-12-30 2024-07-03 SkyLab AG Plant-mineral composition based on aloe barbadensis extract and trimethylglycine for ph-dependent regulation of type 3 aquaporins and transepidermal water flow in deep epidermal layers
CN117623967A (zh) * 2023-11-16 2024-03-01 迪嘉药业集团股份有限公司 一种替米沙坦中间体3-甲基-4-氨基苯甲酸的制备方法

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1194505A (en) * 1968-05-21 1970-06-10 Science Union & Cie Piperidinol Derivatives and Process for Preparing Them
IT1046052B (it) * 1973-10-12 1980-06-30 Sigurta Farmaceutici Spa Processo per la preparazione di i aralchil 4 aminometil piperidin 4 oli
US4348763A (en) * 1980-08-07 1982-09-07 Hewlett-Packard Company Multiple stripe leaky mode laser
US4711703A (en) 1982-02-03 1987-12-08 Orbisphere Corporation Wilmington, Succursale De Collonge-Bellerive Thermal protection method for electroanalytical cell
SU1593569A3 (ru) * 1982-07-30 1990-09-15 Janssen Pharmaceutica Nv Cпocoб пoлучehия пpoизboдhыx n-(3-гидpokcи-4-пипepидиhил)бehзamидa или иx kиcлotho-aддиtиbhыx coлeй
DE3416224C2 (de) * 1983-05-06 1994-05-05 Mitsubishi Chem Ind Verfahren zur Herstellung eines Kohleverflüssigungsöls
US4772630A (en) 1984-11-23 1988-09-20 Ciba-Geigy Corp. Benzamides and their salts
US4722630A (en) 1985-09-20 1988-02-02 The Garrett Corporation Ceramic-metal braze joint
GB8527052D0 (en) 1985-11-02 1985-12-04 Beecham Group Plc Compounds
US4910312A (en) * 1985-11-08 1990-03-20 Warner-Lambert Company Various N-substituted 3-piperidine carboxylic acids or N-substituted 3-pyridinecarboxylic acids and derivatives thereof
US4910193A (en) 1985-12-16 1990-03-20 Sandoz Ltd. Treatment of gastrointestinal disorders
US4746655A (en) * 1987-06-10 1988-05-24 A. H. Robins Company, Incorporated Fused aromatic-spiropiperidine oxazepinones(and thiones)
BE1000689A6 (fr) 1987-07-14 1989-03-14 Donnay Donnay S A Ets Raquette de tennis, de squash ou sport analogue.
NZ225152A (en) * 1987-07-17 1990-04-26 Janssen Pharmaceutica Nv Heterocyclically substituted piperidinyl benzamides as pharmaceuticals
US4906643A (en) 1987-07-17 1990-03-06 Janssen Pharmaceutica N.V. Substituted N-(3-hydroxy-4-piperidinyl)benzamides as gastrointestinal agents
US5130312A (en) 1987-07-17 1992-07-14 Janssen Pharmaceutica N.V. Substituted N-(3-hydroxy-4-piperidinyl)benzamides
JPH0719937B2 (ja) * 1987-09-24 1995-03-06 三井石油化学工業株式会社 高周波用積層板およびその製造方法
US4975439A (en) 1987-09-25 1990-12-04 Janssen Pharmaceutical N.V. Novel substituted N-(1-alkyl-3-hydroxy-4-piperidinyl)benzamides
CA1317940C (en) * 1987-09-25 1993-05-18 Georges H. P. Van Daele Substituted n-(1-alkyl-3-hydroxy-4-piperidinyl)benzamides
US5041454A (en) 1987-09-25 1991-08-20 Janssen Pharmaceutica N.V. Novel substituted N-(1-alkyl-3-hydroxy-4-piperidinyl)benzamides
JP2573017B2 (ja) 1988-03-08 1997-01-16 三洋電機株式会社 ディスクプレーヤ
US5053412A (en) 1990-04-10 1991-10-01 Israel Institute For Biological Research Spiro nitrogen-bridged heterocyclic compounds
US5374637A (en) * 1989-03-22 1994-12-20 Janssen Pharmaceutica N.V. N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives
GB9005014D0 (en) 1990-03-06 1990-05-02 Janssen Pharmaceutica Nv N.(4.piperidinyl)(dihydrobenzofuran or dihydro.2h.benzopyran)carboxamide derivatives
US5103141A (en) 1990-03-08 1992-04-07 U.S. Philips Corporation Switching arrangement for increasing the white life of a high pressure sodium lamp
US5407938A (en) 1990-04-10 1995-04-18 Israel Institute For Biological Research Certain 1-methyl-piperidine-4-spiro-4'-(1'-3'-oxazolines) and corresponding -(1',3' thiazolines)
US5534520A (en) 1990-04-10 1996-07-09 Fisher; Abraham Spiro compounds containing five-membered rings
TW243449B (cs) * 1991-02-15 1995-03-21 Hokuriku Pharmaceutical
WO1993003725A1 (en) 1991-08-20 1993-03-04 Smithkline Beecham Plc 5-ht4 receptor antagonists
SG49153A1 (en) 1991-09-12 1998-05-18 Smithkline Beecham Plc 5-HT4 receptor antagonists
IT1252567B (it) * 1991-12-20 1995-06-19 Italfarmaco Spa Derivati di 5-isochinolinsolfonammidi inibitori delle protein-chinasi
WO1993013101A1 (fr) 1991-12-27 1993-07-08 Yoshitomi Pharmaceutical Industries, Ltd. Compose de pyridonecarboxylate, son utilisation pharmaceutique et compose spiro
EP0625149A1 (en) 1992-02-06 1994-11-23 Smithkline Beecham Plc Benzopyran, benzothiopyran and benzofuran derivatives as 5-ht4 antagonists
JPH05236345A (ja) 1992-02-21 1993-09-10 Nec Ic Microcomput Syst Ltd 画像用垂直フィルタ回路
MX9306311A (es) 1992-10-13 1994-04-29 Smithkline Beecham Plc Compuestos antagonistas del receptor de 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que los contienen
EP0667867A1 (en) 1992-11-05 1995-08-23 Smithkline Beecham Plc Piperidine derivatives as 5-ht4 receptor antagonists
US6127379A (en) * 1993-02-01 2000-10-03 Smithkline Beecham P.L.C. Benzopyran, benzothiopyran and benzofuran derivatives as 5-HT4 antagonists
WO1995026953A1 (en) * 1994-03-30 1995-10-12 Yoshitomi Pharmaceutical Industries, Ltd. Benzoic acid compound and use thereof as medicine
US5864039A (en) * 1994-03-30 1999-01-26 Yoshitomi Pharmaceutical Industries, Ltd. Benzoic acid compounds and use thereof as medicaments
TW490465B (en) * 1994-11-24 2002-06-11 Janssen Pharmaceutica Nv Enterokinetic benzamide, the preparation process and the pharmaceutical compositions thereof
GB9507882D0 (en) * 1995-04-18 1995-05-31 Pharmacia Spa Substituted dihydrobenzofuran derivatives as 5-ht4 agonists
EP0873990A1 (en) * 1995-09-22 1998-10-28 Yoshitomi Pharmaceutical Industries, Ltd. Benzoic acid compounds and medicinal use thereof
US6096761A (en) * 1996-02-15 2000-08-01 Janssen Pharmaceutica N.V. Esters of 3-hydroxy-piperidinemethanol derivatives
ES2208870T3 (es) * 1996-02-15 2004-06-16 Janssen Pharmaceutica N.V. Uso de antagonistas del receptor 5ht4 para resolver los efectos gastrointestinales de los inhibidores de la reabsorcion de serotonina.
TW402591B (en) * 1997-07-11 2000-08-21 Janssen Pharmaceutica Nv Monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
JP2001511934A (ja) 1997-10-31 2001-08-14 ダエウー エレクトロニクス カンパニー,リミテッド 単一動力源によって駆動される駆動メカニズムを有するコンパクトディスクチェンジャー
KR100413150B1 (ko) * 1998-09-10 2003-12-31 에프. 호프만-라 로슈 아게 5-에이치티4 수용체 길항제로서의 디하이드로벤조디옥신 카복스아미드 및 케톤 유도체

Also Published As

Publication number Publication date
JP2002508000A (ja) 2002-03-12
US7790750B2 (en) 2010-09-07
PL338005A1 (en) 2000-09-25
CA2295088C (en) 2007-10-23
US6750349B2 (en) 2004-06-15
HRP20000005A2 (en) 2000-12-31
MY117803A (en) 2004-08-30
CN1117568C (zh) 2003-08-13
KR20010014341A (ko) 2001-02-26
EP0991410B1 (en) 2002-10-30
EE04178B1 (et) 2003-12-15
HK1025047A1 (en) 2000-11-03
NO20000115L (no) 2000-03-13
DE69809050T2 (de) 2003-07-24
US20060142341A1 (en) 2006-06-29
USRE40793E1 (en) 2009-06-23
AR016324A1 (es) 2001-07-04
HK1025093A1 (en) 2000-11-03
KR100500372B1 (ko) 2005-07-11
UA67745C2 (uk) 2004-07-15
EA002619B1 (ru) 2002-06-27
BR9811687A (pt) 2000-09-26
MY123199A (en) 2006-05-31
HUP0002539A3 (en) 2002-03-28
HRP20000005B1 (en) 2008-12-31
KR20010014336A (ko) 2001-02-26
PL190611B1 (pl) 2005-12-30
BG103984A (en) 2000-09-29
HUP0002539A2 (hu) 2000-12-28
US6635643B2 (en) 2003-10-21
BRPI9811688A (pt) 2000-09-26
CZ463899A3 (cs) 2000-04-12
CA2295087A1 (en) 1999-01-21
HUP0004564A3 (en) 2001-08-28
HRP20000006B1 (en) 2009-06-30
TR200000022T2 (tr) 2000-06-21
NO314662B1 (no) 2003-04-28
CN1262621A (zh) 2000-08-09
BG103983A (en) 2000-09-29
BG64230B1 (bg) 2004-06-30
EP0991410A1 (en) 2000-04-12
WO1999002156A1 (en) 1999-01-21
KR100885658B1 (ko) 2009-02-25
HU227424B1 (en) 2011-05-30
IL133917A (en) 2005-05-17
DK0991410T3 (da) 2003-02-24
CN1262674A (zh) 2000-08-09
DE69820065D1 (de) 2004-01-08
IL133918A (en) 2004-06-20
BRPI9811688B8 (pt) 2021-07-06
US20030078427A1 (en) 2003-04-24
US20120028987A1 (en) 2012-02-02
AU8806398A (en) 1999-02-08
ID24161A (id) 2000-07-13
ATE226820T1 (de) 2002-11-15
US20100210657A1 (en) 2010-08-19
EE200000015A (et) 2000-10-16
AU734475B2 (en) 2001-06-14
US6452013B1 (en) 2002-09-17
JP2001509503A (ja) 2001-07-24
CZ295506B6 (cs) 2005-08-17
ES2212330T3 (es) 2004-07-16
IL133917A0 (en) 2001-04-30
AR013361A1 (es) 2000-12-27
DE69820065T2 (de) 2004-08-26
HRP20000006A2 (en) 2000-12-31
CN1195736C (zh) 2005-04-06
TW548103B (en) 2003-08-21
NO20000116D0 (no) 2000-01-10
US20040058958A1 (en) 2004-03-25
EP1206938A1 (en) 2002-05-22
SK184099A3 (en) 2000-09-12
SK284942B6 (sk) 2006-02-02
WO1999002494A1 (en) 1999-01-21
EA200000110A1 (ru) 2000-08-28
PL338008A1 (en) 2000-09-25
RU2213089C2 (ru) 2003-09-27
HUP0004564A2 (hu) 2001-07-30
BG63709B1 (bg) 2002-10-31
US8063070B2 (en) 2011-11-22
NZ502209A (en) 2001-01-26
US20020086879A1 (en) 2002-07-04
US20060142342A1 (en) 2006-06-29
CA2295087C (en) 2007-05-15
SK284632B6 (sk) 2005-08-04
PT991410E (pt) 2003-03-31
NZ502208A (en) 2001-04-27
EP1000028A1 (en) 2000-05-17
CZ297298B6 (cs) 2006-11-15
SI1000028T1 (en) 2004-04-30
TW402591B (en) 2000-08-21
ID24481A (id) 2000-07-20
SK173499A3 (en) 2000-06-12
DE69809050D1 (de) 2002-12-05
SI0991410T1 (en) 2003-04-30
AU8857498A (en) 1999-02-08
EP1000028B1 (en) 2003-11-26
DK1000028T3 (da) 2004-04-05
NO317467B1 (no) 2004-11-01
PL190310B1 (pl) 2005-11-30
NO20000116L (no) 2000-03-07
ATE255092T1 (de) 2003-12-15
US20070037850A1 (en) 2007-02-15
JP4530530B2 (ja) 2010-08-25
IL133918A0 (en) 2001-04-30
NO20000115D0 (no) 2000-01-10
AU747199B2 (en) 2002-05-09
US8318742B2 (en) 2012-11-27
TR200000023T2 (tr) 2000-09-21
CA2295088A1 (en) 1999-01-21
CZ458799A3 (cs) 2000-05-17
PT1000028E (pt) 2004-04-30
BRPI9811688B1 (pt) 2011-10-18

Similar Documents

Publication Publication Date Title
ES2187051T3 (es) Benzamidas gastrocineticas biciclicas de derivados de 4-(aminometil)-piperidina sustituidos en posicion 3 o 4.
BR0010746A (pt) Derivados heterocìclicos úteis com agentes anticâncer
TW430663B (en) Novel substituted piperidines useful for the treatment of allergic diseases
AR038762A1 (es) Derivados de indolina, un proceso para su preparacion, composicion farmaceutica, proceso para la preparacion de dicha composicion y el uso de dichos derivados para la fabricacion de un medicamento
AR030553A1 (es) Uso de derivados de tiazolilo 2,4-disustituidos para la fabricacion de un medicamento para la prevencion o el tratamiento de enfermedades mediadas a traves de citoquinas, derivados de tiazolilo 2,4-disustituidos, composiciones farmaceuticas que los comprenden, procesos para preparar dichos derivados
FR2662162B1 (fr) Nouveaux derives de l'amino piperidine, de l'amino pyrrolidine et de l'amino perhydroazepine, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
NO305028B1 (no) AnalogifremgangsmÕte for fremstilling av terapeutisk aktive pyridin N-oxydderivater av diarylmethylpiperidiner eller piperaziner
MX9300786A (es) Compuestos hipolipidaemicos.
SE9904738D0 (sv) Novel compounds
ES2158778B1 (es) Compuestos de sales de paroxetina, su preparacion y uso, y composiciones farmaceuticas que los contienen.
BR9916491A (pt) 4-(aminometil)-piperidina benzamidas para tratamento de distúrbios gastrintestinais
AR029373A1 (es) Metodo para el tratamiento de migranas, utilizando compuestos antagonistas selectivos de los receptores iglur5, uso de dichos compuestos antagonistas selectivos en la manufactura de medicamentos para el tratamiento de migranas y dichos compuestos antagonistas
MX9300616A (es) Compuestos antagonistas del receptor 5-hidroxitriptamina, proceso para su prepararcion y composicion farmaceutica que los contiene
NO942952L (no) 11-benzaldoksin-17 ater, fremgangsmåte for deres fremstilling samt legemiddel inneholdende slike
AR008875A1 (es) Derivados de 2-cianoiminoimidazol inhibidores de pde iv, procedimiento para su preparacion, composicion que los contienen, procedimiento para preparar dicha composicion y uso de dichos compuestos para la preparacion de medicamentos.
AR006518A1 (es) Esteres de derivados de 1,4-piperidina disustituida, un procedimiento para su preparacion, una composicion farmaceutica que los contiene y un procedimiento para su preparacion
MX2024011914A (es) Derivados de n-(pirrolidin-3-il o piperidin-4-il)acetamida
AR036131A1 (es) Derivados de benzo (g) quinolina, un proceso para su preparacion, una composicion farmaceutica y el uso de dichos derivados para la fabricacion de un medicamento
DK360584D0 (da) Triazol-pyrimidinderivater og fremgangsmaade til fremstilling deraf samt disses terapeutiske anvendelse som cardiotoniske midler
NO20045132L (no) Benzo(c)kinolizinderivater, deres fremstilling og anvendelse som 5alfa- reduktaseinhibitorer
UY27001A1 (es) Derivados de la indolilpiperidina como agentes antihistamínicos y antialérgicos
ES2088567T3 (es) Empleo de derivados de la 2-iminotioazolidin-4-ona como nuevos productos activos para medicamentos.
GB1164496A (en) 0-Oxaphenanthridine Derivatives and Method for the Preparation
ES380930A1 (es) Un procedimiento de preparacion de nuevas 2-hidroxi-5-aminobenzamidas.
ATE48840T1 (de) Benzimidazole.